{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:22:37Z","timestamp":1761765757240},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Metabolic syndrome (MetS) and lower urinary tract symptoms (LUTS) are often associated. Bladder detrusor hyper-contractility\u2014a major LUTS determinant\u2014is characterized by increased Ras homolog gene family, member A\/Rho-associated protein kinase (RhoA\/ROCK) signaling, which is often upregulated in MetS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>This study investigated the effects of tadalafil dosing on RhoA\/ROCK signaling in bladder, in a rabbit model of high-fat diet (HFD)-induced MetS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Adult male rabbits feeding a HFD for 12 weeks. A subset of HFD animals was treated with tadalafil (2 mg\/kg\/day, 1 week: the last of the 12 weeks) and compared with HFD and control (feeding a regular diet) rabbits.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>In vitro contractility studies to evaluate the relaxant effect of the selective ROCK inhibitor, Y-27632, in carbachol precontracted bladder strips. Evaluation of RhoA activation by its membrane translocation. Immunohistochemistry for ROCK expression has been performed to evaluate ROCK expression in bladder from the different experimental groups. mRNA expression of inflammation, pro-fibrotic markers by quantitative RT-PCR has been performed to evaluate the effect of tadalafil on MetS-induced inflammation and fibrosis within the bladder. The in vitro effect of tadalafil on RhoA\/ROCK signaling in bladder smooth muscle cells was evaluated by using chemotaxis assay.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Bladder strips from HFD rabbits showed hyper-responsiveness to Y-27632, indicating RhoA\/ROCK overactivity in HFD bladder compared with matched controls. Accordingly, the fraction of activated (translocated to the membrane) RhoA as well as ROCK expression are increased in HFD bladder. Tadalafil dosing normalized HFD-induced bladder hypersensitivity to Y-27632, by reducing RhoA membrane translocation and ROCK overexpression. Tadalafil dosing reduced mRNA expression of inflammatory, pro-fibrotic, and hypoxia markers. A direct inhibitory effect of tadalafil on RhoA\/ROCK signaling in bladder smooth muscle cell was demonstrated by using chemotaxis assay. Pre-treatment with tadalafil inhibited both basal and PDGF-induced migration of bladder smooth muscle cells.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Tadalafil dosing reduced RhoA\/ROCK signaling and smooth muscle overactivity in an animal model of MetS-associated bladder alterations. Our findings suggest a novel mechanism of action of tadalafil in alleviating LUTS in MetS patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/jsm.12478","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T08:48:39Z","timestamp":1393404519000},"page":"1159-1172","source":"Crossref","is-referenced-by-count":20,"title":["Tadalafil Effect on Metabolic Syndrome-Associated Bladder Alterations: An Experimental Study in a Rabbit Model"],"prefix":"10.1093","volume":"11","author":[{"given":"Linda","family":"Vignozzi","sequence":"first","affiliation":[{"name":"Sexual Medicine and Andrology Unit \u00a0 \u00a0 , Florence , Italy"},{"name":"Department of Experimental and Clinical Biomedical Sciences \u00a0 \u00a0 , Florence , Italy"},{"name":"University of Florence \u00a0 \u00a0 , Florence , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Filippi","sequence":"additional","affiliation":[{"name":"Interdepartmental Laboratory of Functional and Cellular Pharmacology of Reproduction \u00a0 \u00a0 , Florence , Italy"},{"name":"Department of Experimental and Clinical Biomedical Sciences and Department of NEUROFARBA \u00a0 \u00a0 , Florence , Italy"},{"name":"University of Florence \u00a0 \u00a0 , Florence , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Comeglio","sequence":"additional","affiliation":[{"name":"Sexual Medicine and Andrology Unit \u00a0 \u00a0 , Florence , Italy"},{"name":"Department of Experimental and Clinical Biomedical Sciences \u00a0 \u00a0 , Florence , Italy"},{"name":"University of Florence \u00a0 \u00a0 , Florence , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Cellai","sequence":"additional","affiliation":[{"name":"Sexual Medicine and Andrology Unit \u00a0 \u00a0 , Florence , Italy"},{"name":"Department of Experimental and Clinical Biomedical Sciences \u00a0 \u00a0 , Florence , Italy"},{"name":"University of Florence \u00a0 \u00a0 , Florence , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Morelli","sequence":"additional","affiliation":[{"name":"Section of Anatomy and Histology \u00a0 \u00a0 , Florence , Italy"},{"name":"Department of Experimental and Clinical Medicine \u00a0 \u00a0 , Florence , Italy"},{"name":"University of Florence \u00a0 \u00a0 , Florence , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Maneschi","sequence":"additional","affiliation":[{"name":"Sexual Medicine and Andrology Unit \u00a0 \u00a0 , Florence , Italy"},{"name":"Department of Experimental and Clinical Biomedical Sciences \u00a0 \u00a0 , Florence , Italy"},{"name":"University of Florence \u00a0 \u00a0 , Florence , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Sarchielli","sequence":"additional","affiliation":[{"name":"Section of Anatomy and Histology \u00a0 \u00a0 , Florence , Italy"},{"name":"Department of Experimental and Clinical Medicine \u00a0 \u00a0 , Florence , Italy"},{"name":"University of Florence \u00a0 \u00a0 , Florence , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Gacci","sequence":"additional","affiliation":[{"name":"Urology Unit \u00a0 \u00a0 , Florence , Italy"},{"name":"Department of Experimental and Clinical Medicine \u00a0 \u00a0 , Florence , Italy"},{"name":"University of Florence \u00a0 \u00a0 , Florence , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Carini","sequence":"additional","affiliation":[{"name":"Urology Unit \u00a0 \u00a0 , Florence , Italy"},{"name":"Department of Experimental and Clinical Medicine \u00a0 \u00a0 , Florence , Italy"},{"name":"University of Florence \u00a0 \u00a0 , Florence , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella Barbara","family":"Vannelli","sequence":"additional","affiliation":[{"name":"Section of Anatomy and Histology \u00a0 \u00a0 , Florence , Italy"},{"name":"Department of Experimental and Clinical Medicine \u00a0 \u00a0 , Florence , Italy"},{"name":"University of Florence \u00a0 \u00a0 , Florence , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Maggi","sequence":"additional","affiliation":[{"name":"Sexual Medicine and Andrology Unit \u00a0 \u00a0 , Florence , Italy"},{"name":"Department of Experimental and Clinical Biomedical Sciences \u00a0 \u00a0 , Florence , Italy"},{"name":"University of Florence \u00a0 \u00a0 , Florence , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,5,1]]},"reference":[{"key":"2024032602363946600_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","article-title":"Standardisation Sub-Committee of the International Continence Society. The standardization of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society","volume":"61","author":"Abrams","year":"2003","journal-title":"Urology"},{"key":"2024032602363946600_bib2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.eururo.2006.02.018","article-title":"A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder","volume":"49","author":"Chapple","year":"2006","journal-title":"Eur Urol"},{"key":"2024032602363946600_bib3","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study","volume":"50","author":"Irwin","year":"2006","journal-title":"Eur Urol"},{"key":"2024032602363946600_bib4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/nau.20999","article-title":"Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: Pathophysiology and mechanism(s) of action","volume":"30","author":"Andersson","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"2024032602363946600_bib5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrurol.2011.112","article-title":"Urological aspects of the metabolic syndrome","volume":"8","author":"Hammarsten","year":"2011","journal-title":"Nat Rev Urol"},{"key":"2024032602363946600_bib6","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.juro.2008.01.029","article-title":"Birth weight, abdominal obesity and the risk of lower urinary tract symptoms in a population based study of Swedish men","volume":"179","author":"Laven","year":"2008","journal-title":"J Urol"},{"key":"2024032602363946600_bib7","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.ju.0000139995.85780.d8","article-title":"Association of hypertension with symptoms of benign prostatic hyperplasia","volume":"172","author":"Michel","year":"2004","journal-title":"J Urol"},{"key":"2024032602363946600_bib8","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0022-5347(05)67529-5","article-title":"Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia","volume":"163","author":"Michel","year":"2000","journal-title":"J Urol"},{"key":"2024032602363946600_bib9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1442-2042.2009.02276.x","article-title":"Lower urinary tract symptoms in relation to lifestyle and medical conditions in Japanese workers","volume":"16","author":"Tomita","year":"2009","journal-title":"Int J Urol"},{"key":"2024032602363946600_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00345-010-0605-8","article-title":"Members of the Florey Adelaide Male Ageing Study. Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men","volume":"29","author":"Martin","year":"2011","journal-title":"World J Urol"},{"key":"2024032602363946600_bib11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/pros.22623","article-title":"Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation","volume":"73","author":"Vignozzi","year":"2013","journal-title":"Prostate"},{"key":"2024032602363946600_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/pcan.2012.44","article-title":"Metabolic syndrome and lower urinary tract symptoms: The role of inflammation","volume":"16","author":"Gacci","year":"2013","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2024032602363946600_bib13","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2353\/ajpath.2008.070594","article-title":"Development of diabesity in mice with neuronal deletion of Shp2 tyrosine phosphatase","volume":"172","author":"Krajewska","year":"2008","journal-title":"Am J Pathol"},{"key":"2024032602363946600_bib14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/nau.20908","article-title":"Genetics and the lower urinary tract","volume":"29","author":"Norton","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"2024032602363946600_bib15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1464-410X.2007.07069.x","article-title":"An animal model to study lower urinary tract symptoms and erectile dysfunction: The hyperlipidaemic rat","volume":"100","author":"Rahman","year":"2007","journal-title":"BJU Int"},{"key":"2024032602363946600_bib16","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/S0022-5347(05)68995-1","article-title":"Atherosclerosis-induced chronic ischemia causes bladder fibrosis and non-compliance in the rabbit","volume":"161","author":"Azadzoi","year":"1999","journal-title":"J Urol"},{"key":"2024032602363946600_bib17","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.juro.2007.05.114","article-title":"Alterations of M 2,3 -Muscarinic Receptor Protein and mRNA Expression in the Bladder of the Fructose Fed Obese Rat","volume":"178","author":"Tong","year":"2007","journal-title":"Urology"},{"key":"2024032602363946600_bib18","first-page":"173","article-title":"Alterations in M2-muscarinic receptor protein and mRNA in diabetic rat urinary bladders","volume":"277","author":"Tong","year":"1999","journal-title":"NeurosciLett"},{"key":"2024032602363946600_bib19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000056164","article-title":"Alteration of M3 subtype muscarinic receptors in the rat urinary bladder","volume":"64","author":"Tong","year":"2001","journal-title":"Pharmacology"},{"key":"2024032602363946600_bib20","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1111\/j.1743-6109.2009.01467.x","article-title":"Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome","volume":"6","author":"Filippi","year":"2009","journal-title":"J Sex Med"},{"key":"2024032602363946600_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1743-6109.2010.02073.x","article-title":"Farnesoid X receptor activation improves erectile function in animal models of metabolic syndrome and diabetes","volume":"8","author":"Vignozzi","year":"2011","journal-title":"J Sex Med"},{"key":"2024032602363946600_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1530\/JOE-11-0289","article-title":"Testosterone protects from metabolic syndrome-associated prostate inflammation: An experimental study in rabbit","volume":"212","author":"Vignozzi","year":"2012","journal-title":"J Endocrinol"},{"key":"2024032602363946600_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jsbmb.2012.02.007","article-title":"Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome","volume":"132","author":"Morelli","year":"2012","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2024032602363946600_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/JOE-13-0109","article-title":"FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS","volume":"218","author":"Maneschi","year":"2013","journal-title":"J Endocrinol"},{"key":"2024032602363946600_bib25","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/pros.22584","article-title":"Mechanism of action of phosphodiesterasetype 5 inhibition in metabolic syndrome-associated prostate alterations: An experimental study in the rabbit","volume":"73","author":"Morelli","year":"2013","journal-title":"Prostate"},{"key":"2024032602363946600_bib26","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/pros.20463","article-title":"BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA\/Rho kinase signaling in rat and human bladder","volume":"67","author":"Morelli","year":"2007","journal-title":"Prostate"},{"key":"2024032602363946600_bib27","first-page":"97","article-title":"Simultaneous analysis of families of sigmoidal curves: Applications to biossay, radioligand assay, and physiological dose-response curves","volume":"235","author":"De Lean","year":"1978","journal-title":"Am J Physiol"},{"key":"2024032602363946600_bib28","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s12265-012-9397-0","article-title":"The actin-MRTF-SRF gene regulatory axis and myofibroblast differentiation","volume":"5","author":"Small","year":"2012","journal-title":"J Cardiovasc Transl Res."},{"key":"2024032602363946600_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/BJ20041638","article-title":"PAK and other Rho-associated kinases\u2013effectors with surprisingly diverse mechanisms of regulation","volume":"386","author":"Zhao","year":"2005","journal-title":"Biochem J"},{"key":"2024032602363946600_bib30","doi-asserted-by":"crossref","first-page":"37385","DOI":"10.1074\/jbc.274.52.37385","article-title":"inhibitory phosphorylation site for rho-associated kinase on smooth muscle myosin phosphatase","volume":"52","author":"Feng","year":"1999","journal-title":"J Biol Chem"},{"key":"2024032602363946600_bib31","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1152\/physrev.00023.2003","article-title":"Ca2\u00fe sensitivity of smooth muscle and nonmuscle myosin II: Modulated by g proteins, kinases, and myosin phosphatase","volume":"83","author":"Somlyo","year":"2003","journal-title":"Physiol Rev"},{"key":"2024032602363946600_bib32","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1124\/pr.56.4.4","article-title":"Pharmacology of the lower urinary tract: Basis for current and future treatments of urinary incontinence","volume":"56","author":"Andersson","year":"2004","journal-title":"Pharmacol Rev"},{"key":"2024032602363946600_bib33","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.bjp.0705109","article-title":"Expression and functional role of Rho-kinase in rat urinary bladder smooth muscle","volume":"138","author":"Wibberley","year":"2003","journal-title":"Br J Pharmacol"},{"key":"2024032602363946600_bib34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1124\/jpet.103.058255","article-title":"Signal transduction underlying carbachol-induced contraction of rat urinary bladder. II. Protein kinases","volume":"308","author":"Fleichman","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"2024032602363946600_bib35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1124\/jpet.103.058248","article-title":"Signal transduction underlying carbachol-induced contraction of rat urinary bladder. I. Phospholipases and Ca2\u00fe sources","volume":"308","author":"Schneider","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"2024032602363946600_bib36","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.ju.0000130419.32165.6b","article-title":"Ca2\u00fe sensitization in contraction of human bladder smooth muscle","volume":"172","author":"Takahashi","year":"2004","journal-title":"J Urol"},{"key":"2024032602363946600_bib37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/nau.20625","article-title":"Obstruction alters muscarinic receptor-coupled RhoA\/Rho-kinase pathway in the urinary bladder of the rat","volume":"28","author":"Takahashi","year":"2009","journal-title":"Neurourol Urodyn"},{"key":"2024032602363946600_bib38","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.urology.2011.12.032","article-title":"Hydroxyfasudil ameliorates bladder dysfunction in male spontaneously hypertensive rats","volume":"79","author":"Inoue","year":"2012","journal-title":"Urology"},{"key":"2024032602363946600_bib39","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1442-2042.2009.02375.x","article-title":"Effect of the rho-kinase inhibitor hydroxyfasudil on bladder overactivity: An experimental rat model","volume":"16","author":"Masago","year":"2009","journal-title":"Int J Urol"},{"key":"2024032602363946600_bib40","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.eururo.2013.04.042","article-title":"Future direction in pharmacotherapy for Non-neurogenic male lower urinary tract symptoms","volume":"64","author":"Soler","year":"2013","journal-title":"Eur Urol"},{"key":"2024032602363946600_bib41","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.2337\/db11-1763","article-title":"Inhibition of TNF-\u03b1 improves the bladder dysfunction that is associated with type 2 diabetes","volume":"61","author":"Wang","year":"2012","journal-title":"Diabetes"},{"key":"2024032602363946600_bib42","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.eururo.2012.02.033","article-title":"A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with \u03b1-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"61","author":"Gacci","year":"2012","journal-title":"Eur Urol"},{"key":"2024032602363946600_bib43","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.eururo.2012.09.006","article-title":"The mechanism of action of phosphodiesterase type 5 inhibitors in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia","volume":"63","author":"Giuliano","year":"2013","journal-title":"Eur Urol"},{"key":"2024032602363946600_bib44","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/jsm.12212","article-title":"Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies","volume":"10","author":"Porst","year":"2013","journal-title":"J Sex Med"},{"key":"2024032602363946600_bib45","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1111\/j.1743-6109.2012.02821.x","article-title":"Tadalafil enhances the inhibitory effects of tamsulosin on neurogenic contractions of human prostate and bladder neck","volume":"9","author":"Angulo","year":"2012","journal-title":"J Sex Med"},{"key":"2024032602363946600_bib46","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1743-6109.2011.02504.x","article-title":"Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: Results of a randomized, placebo-controlled, double-blind study","volume":"9","author":"Egerdie","year":"2012","journal-title":"J Sex Med"},{"key":"2024032602363946600_bib47","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/jsm.12386","article-title":"Effectiveness of Tadalafil 5 mg once daily in the treatment of men with lower urinary tract symptoms suggestive to benign prostatic hyperplasia with or without erectile dysfunction: Results from naturalistic observational TadaLutsEd study","volume":"11","author":"Bechara","year":"2014","journal-title":"J Sex Med"},{"key":"2024032602363946600_bib48","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/jsm.12357","article-title":"A comparative randomized prospective study to evaluate efficacy and safety of combination of tamsulosin and Tadalafil versus Tamsulosin or Tadalafil alone in patients with lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"11","author":"Singh","year":"2014","journal-title":"J Sex Med"},{"key":"2024032602363946600_bib49","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1210\/en.2006-1079","article-title":"Characterization and functional role of androgen-dependent PDE5 activity in the bladder","volume":"148","author":"Filippi","year":"2007","journal-title":"Endocrinology"},{"key":"2024032602363946600_bib50","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/j.1464-410X.2010.09759.x","article-title":"Activity of phosphodiesterase type 5 inhibitors in patients with lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"107","author":"Zhao","year":"2011","journal-title":"Br J Urol Int"},{"key":"2024032602363946600_bib51","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1743-6109.2009.01558.x","article-title":"Acute vardenafil administration improbe bladder oxygenation in spontaneously hypertensive rats","volume":"7","author":"Morelli","year":"2010","journal-title":"J Sex Med"},{"key":"2024032602363946600_bib52","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1111\/j.1743-6109.2011.02416.x","article-title":"Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats","volume":"8","author":"Morelli","year":"2011","journal-title":"J Sex Med"},{"key":"2024032602363946600_bib53","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/j.1743-6109.2009.01249.x","article-title":"Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA\/Rho kinase signaling pathway in spontaneously hypertensive rats","volume":"6","author":"Morelli","year":"2009","journal-title":"J Sex Med"},{"key":"2024032602363946600_bib54","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1111\/j.1743-6109.2012.02946.x","article-title":"Testosterone\/estradiol ratio regulates NO-inducedbladderrelaxation and responsiveness to PDE5 inhibitors","volume":"9","author":"Vignozzi","year":"2012","journal-title":"J Sex Med"},{"key":"2024032602363946600_bib55","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/pros.22723","article-title":"Opposite effects of tamoxifen on metabolicsyndrome-induced bladder and prostate alterations: A role for GPR30\/GPER?","volume":"74","author":"Comeglio","year":"2014","journal-title":"Prostate"},{"key":"2024032602363946600_bib56","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1111\/j.1743-6109.2010.01811.x","article-title":"Sex steroid receptors in male human bladder: expression and biological function","volume":"7","author":"Chavalmane","year":"2010","journal-title":"J Sex Med"},{"key":"2024032602363946600_bib57","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1743-6109.2010.02152.x","article-title":"Exposure to phosphodiesterase type 5 inhibitors stimulates aromatase expression in human adipocytes in vitro","volume":"8","author":"Aversa","year":"2011","journal-title":"J Sex Med"},{"key":"2024032602363946600_bib58","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1092053","article-title":"Cell migration: Integrating signals from front to back","volume":"302","author":"Ridley","year":"2003","journal-title":"Science"},{"key":"2024032602363946600_bib59","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/j.1460-2075.1989.tb03477.x","article-title":"The mammalian G protein rhoC is ADP-ribosylated by Clostridium botulinum exoenzyme C3 and affects actin microfilaments in Vero cells","volume":"8","author":"Chardin","year":"1989","journal-title":"EMBO J"},{"key":"2024032602363946600_bib60","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.bcp.2012.07.023","article-title":"Sildenafil stimulates the expression of gaseous monoxide-generating enzymes in vascular smooth muscle cells via distinct signaling pathways","volume":"84","author":"Liu","year":"2012","journal-title":"Biochem Pharmacol"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515307712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515307712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/11\/5\/1159\/48359833\/jsm_11_5_1159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/11\/5\/1159\/48359833\/jsm_11_5_1159.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T03:13:56Z","timestamp":1711422836000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/11\/5\/1159\/6958341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,1]]},"references-count":60,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5,1]]},"published-print":{"date-parts":[[2014,5,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jsm.12478","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,5]]},"published":{"date-parts":[[2014,5,1]]}}}